These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7533342)

  • 41. Heterogenous expression of decay accelerating factor and CD59/membrane attack complex inhibition factor on paroxysmal nocturnal haemoglobinuria (PNH) erythrocytes.
    Shichishima T; Terasawa T; Hashimoto C; Ohto H; Uchida T; Maruyama Y
    Br J Haematol; 1991 Aug; 78(4):545-50. PubMed ID: 1716957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful generation of transgenic pigs for human decay-accelerating factor and human leucocyte antigen DQ.
    Tu CF; Hsieh SL; Lee JM; Yang LL; Sato T; Lee KH; Weng CN; Mao SJ; Tsuji K; Lee CJ
    Transplant Proc; 2000 Aug; 32(5):913-5. PubMed ID: 10936271
    [No Abstract]   [Full Text] [Related]  

  • 43. [Costimulatory molecules, CD 80 and CD 86].
    Takasaki Y
    Ryumachi; 1998 Aug; 38(4):623-30. PubMed ID: 9785992
    [No Abstract]   [Full Text] [Related]  

  • 44. Protection of thyroid cancer cells by complement-regulatory factors.
    Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
    Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter.
    Murakami H; Nagashima H; Takahagi Y; Fujimura T; Miyagawa S; Okabe M; Seya T; Shigehisa T; Taniguchi N; Shirakura R; Kinoshita T
    Transplant Proc; 2000 Nov; 32(7):2505-6. PubMed ID: 11120269
    [No Abstract]   [Full Text] [Related]  

  • 46. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.
    Bergelson JM; Chan M; Solomon KR; St John NF; Lin H; Finberg RW
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6245-8. PubMed ID: 7517044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of pigs transgenic for human decay accelerating factor.
    Langford GA; Yannoutsos N; Cozzi E; Lancaster R; Elsome K; Chen P; Richards A; White DJ
    Transplant Proc; 1994 Jun; 26(3):1400-1. PubMed ID: 7518134
    [No Abstract]   [Full Text] [Related]  

  • 49. A study of human DAF, CD59, MCP transgene in xenotransplantation.
    Chen S; Chen G; Cai CC; Wang XM; Guo H; Shen SQ; Wang H; Wu Y; Li GX; Huang J; Li WX; Wei QX; Sun FZ
    Transplant Proc; 2001; 33(7-8):3851-2. PubMed ID: 11750639
    [No Abstract]   [Full Text] [Related]  

  • 50. Heterogeneity of interactions mediated by membrane glycoproteins of lymphocytes.
    Barclay AN; Brown MH
    Biochem Soc Trans; 1997 Feb; 25(1):224-8. PubMed ID: 9056875
    [No Abstract]   [Full Text] [Related]  

  • 51. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
    White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
    Transplant Proc; 1992 Apr; 24(2):474-6. PubMed ID: 1373541
    [No Abstract]   [Full Text] [Related]  

  • 52. Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC.
    Matthes T; Tullen E; Poole J; Banks J; Nagy M; Stelling MJ; Boehlen F; Michel M; Beris P; Hustinx H; Crew V; Daniels G
    Transfusion; 2002 Nov; 42(11):1448-57. PubMed ID: 12421218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.
    Rosengard AM; Cary N; Horsley J; Belcher C; Langford G; Cozzi E; Wallwork J; White DJ
    Transplant Proc; 1995 Feb; 27(1):326-7. PubMed ID: 7533400
    [No Abstract]   [Full Text] [Related]  

  • 54. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases.
    Reiser H; Stadecker MJ
    N Engl J Med; 1996 Oct; 335(18):1369-77. PubMed ID: 8857022
    [No Abstract]   [Full Text] [Related]  

  • 55. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
    Lublin DM; Coyne KE
    J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Morphoea lesions are associated with aberrant expression of membrane cofactor protein and decay accelerating factor in vascular endothelium.
    Venneker GT; Das PK; Naafs B; Tigges AJ; Bos JD; Asghar SS
    Br J Dermatol; 1994 Aug; 131(2):237-42. PubMed ID: 7522514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs.
    Bennet W; Björkland A; Sundberg B; Brandhorst D; Brendel MD; Richards A; White DJ; Nilsson B; Groth CG; Korsgren O
    Transplantation; 2001 Jul; 72(2):312-9. PubMed ID: 11477359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complement regulatory proteins at the feto-maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein (CD46) and decay accelerating factor (CD55).
    Holmes CH; Simpson KL; Okada H; Okada N; Wainwright SD; Purcell DF; Houlihan JM
    Eur J Immunol; 1992 Jun; 22(6):1579-85. PubMed ID: 1376264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genetic defect of PNH.
    Kinoshita T
    Clin Exp Immunol; 1994 Aug; 97 Suppl 2(Suppl 2):3-4. PubMed ID: 7520848
    [No Abstract]   [Full Text] [Related]  

  • 60. Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection.
    Verbakel CA; Bonthuis F; Eerhart SE; van Dixhoorn M; Grosveld F; Marquet RL; IJzermans JN
    Transplant Proc; 2000 Aug; 32(5):903-4. PubMed ID: 10936266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.